NCT01651377View on ClinicalTrials.gov

Pramipexole as a Treatment for Cocaine Dependence

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Cocaine AddictionCocaine AbuseCocaine DependenceSubstance Abuse
Interventions
DRUG

Pramipexole

Participants will receive pramipexole ER 0.375, .075, 1.5, 2.25, and 3mg/d in an ascending-dose pattern.

DRUG

Placebo

Participants will receive matching placebo pills. The placebo group is included to maintain the blind, rather than as a comparison group.

Trial Locations (1)

77030

Michael E. DeBakey VA Medical Center, Houston

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Baylor College of Medicine

OTHER

NCT01651377 - Pramipexole as a Treatment for Cocaine Dependence | Biotech Hunter | Biotech Hunter